Investigating the safety of an experimental drug in people with ALS
The purpose of this Phase 1b/2 study is to evaluate an experimental drug, ALN-SOD, in a small group of participants for the first time. Phase 1 trials assess safety, determine appropriate dosage ranges and identify potential side effects. This study focuses on individuals with amyotrophic lateral sclerosis (ALS) who have a change in the SOD1 gene. The primary aim of the study is to see how safe and tolerable the study treatment (ALN-SOD) is in humans.